Forward Citations = 1,340

Loading Chart...

7 inventors (with patents filed for the assignee):

Troy Chapman (3 out of 4 patents)

Hugh L Narciso, Jr (3 out of 24 patents)

Mike Hogendijk (2 out of 2 patents)

4. Michael Hogendijk (1 out of 52 patents)

5. Fritz French (1 out of 2 patents)

6. Francis G Duhaylongsod (1 out of 12 patents)

7. Stephen Morales (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. D440304 - Direct fluid-delivery system (2001-04-11),

2. 6176864 - Anastomosis device and method (2001-01-23),

3. 6113588 - Transillumination catheter and method (2000-09-05),

4. 6110188 - Anastomosis method (2000-08-29),

5. 6095997 - Intraluminal shunt and methods of use (2000-08-01),

6. 6080175 - Surgical cutting instrument and method of use (2000-06-27),

7. 6051007 - Sternal closure device and instruments therefor (2000-04-18),

Company Overview

Corvascular, Inc. is a medical device company focused on developing innovative solutions for the treatment of cardiovascular disease. Our mission is to improve patient outcomes through the development of next-generation treatments for a wide range of cardiovascular conditions. With a team of experienced professionals and a commitment to cutting-edge research and development, Corvascular aims to revolutionize the field of cardiovascular medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

7 Patents

#177 in Menlo Park, CA

#9,501 in California

#39,907 in US

Menlo Park, CA, United States of America

Corvascular, Inc.

Forward Citations = 1,340

7 inventors:

Troy Chapman (3 out of 4 patents)

Hugh L Narciso, Jr (3 out of 24 patents)

Mike Hogendijk (2 out of 2 patents)

4. Michael Hogendijk (1 out of 52 patents)

5. Fritz French (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Corvascular, Inc.. Retrieved from https://idiyas.com/company/corvascular

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]